Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Looking back a century, Chlorobutanol came out of the laboratory era when preservation and stability in medicines posed huge challenges. The old compounding pharmacists were always searching for ways to keep preparations free of bacterial contamination well before refrigeration or modern packaging arrived. The chemical first emerged in the late 1800s as a result of the push to improve antimicrobial properties in tinctures and injectable products. Over the decades, advances in chemical synthesis allowed manufacturers to create high-purity Chlorobutanol, and regulatory guidelines such as those found in the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards shaped the chemical’s benchmark for consistency. Most people might not notice the connection, but Chlorobutanol's journey grew right alongside the evolution of industrial pharmacy and the development of standards-driven ingredient sourcing worldwide.
Chlorobutanol has carved out a niche as a reliable preservative in various pharmaceutical formulations. The chemical appears in multi-dose eye drops, injectable medications, topical ointments, and even as a stabilizer in laboratory reagents. Demand stays strong because Chlorobutanol blends antimicrobial action with a relatively mild side effect profile at typical concentrations. Stewardship doesn't simply rest on the science—manufacturers understand that meeting BP, EP, and USP standards demonstrates a commitment to quality, safety, and repeatable performance that practitioners and regulators have come to expect.
A visual tells its own story: Chlorobutanol often appears as white crystalline granules with a faint, sweet odour. Chemically, it carries the formula C4H7Cl3O and a molar mass of about 177.46 g/mol. Melting point falls in the 76-79°C range, making the substance fairly stable for standard storage and transport. The compound dissolves well in ethanol, ether, and oils, which makes it a tool for both hydrophilic and lipophilic preparations. Unlike some more volatile or reactive compounds, Chlorobutanol does not require extraordinary storage measures—room temperature, away from direct sunlight, usually suffices to keep its characteristics intact.
Quality-assured shipments of Chlorobutanol come with detailed specification sheets, listing assay results (not less than 98% purity by GC or HPLC), moisture content, melting range, and results from tests for related substances and heavy metals. Each label tells a compliance story—batch/lot number, manufacturing and expiry dates, the pharmacopoeial standard it adheres to, safety warnings, and intended pharmaceutical grade. Attention to documentation has grown because traceability has moved front and center—once upon a time, the origin and handling of chemicals could get lost in a paper trail, but today, regulatory scrutiny leaves no wiggle room.
Most commercial process routes for Chlorobutanol employ a Trichloroacetaldehyde and acetone condensation in the presence of a base like sodium carbonate. Reaction control determines the product quality, so skilled operators check temperature and reactant ratios carefully to avoid unwanted byproducts. After the reaction, purification takes place by crystallization and filtration, followed by drying and milling steps to achieve the desired granule size. Process changes over the years—switching from batch to continuous systems, recycling solvents, using closed vessels for improved safety—stem from both environmental regulation and a push for higher throughput. In practice, facilities that run under GMP conditions intensely monitor each stage to guard against impurities that may not show up until well after production ends.
Chlorobutanol itself reacts fairly lazily under ordinary conditions, which suits its preservative function. Still, hydrolysis can occur in strongly alkaline or acidic environments, breaking the compound down into its respective alcohol and chloroform fragments. Some specialty syntheses use Chlorobutanol as a starting material or intermediate, exploiting its trichloromethyl moiety for further chemical modification. I’ve seen it referenced in research projects aiming for new antimicrobials or as a precursor in laboratory-scale halogenation reactions. These side uses never match the scale of the pharmaceutical applications but show the substance holds value outside strict preservation roles.
Across continents and textbooks, Chlorobutanol answers to several names. 1,1,1-Trichloro-2-methyl-2-propanol comes up on chemical inventories, and older texts might label it Chlorbutol or Chloretone. Commercially, the compound might ship as 'Chlorobutanol BP,' 'Chlorobutanol EP,' or 'Chlorobutanol USP,' reflecting regional pharmacopoeia standards. The string of identifiers—CAS Number 57-15-8, EC Number 200-322-8—keeps the marketplace clear. In practice, these synonyms migrate with international trade, cutting down procurement confusion and reducing the risk of mix-ups in multilingual settings.
Workplaces dealing with Chlorobutanol strictly enforce exposure controls. Glove and goggle use becomes routine because, at higher exposure levels, the chemical can act as an irritant to skin and mucous membranes. Though considered safe at ppm levels in end-user formulations, bulk handling warrants respect for both inhalation and ingestion hazards. Material Safety Data Sheets (MSDS) call for workplace ventilation and prompt cleanup of spills. Many facilities segregate storage for Chlorobutanol and document bi-annual training on chemical handling. In my mind, this vigilance pays off. Even though the scientific literature suggests Chlorobutanol’s acute toxicity sits lower than for some older preservatives, long-term operators treat it no differently from more dangerous merchandise. That attitude—driven by hard-won lessons—guards both worker health and supply integrity.
Pharmaceuticals represent only the tip of Chlorobutanol’s practical iceberg. Most know it from eye drops or injectable mixtures, but the preservative quietly underpins everything from local anesthetic solutions to nasal sprays to veterinary drugs. Hospitals value its presence in diagnostic reagents since reliability in sterility protects vulnerable patient populations. Research labs rely on Chlorobutanol as part of fixative solutions for microscopy, and certain cosmetics even draw on its antimicrobial punch. Each of these uses demands different purity grades and handling protocols, yet all trace back to the same principle: keep microbes at bay so that delicate or long-lived products function as intended until the end-user finally opens the package.
Pharmaceutical researchers regularly revisit old chemicals like Chlorobutanol looking for ways to improve safety margins, extend shelf lives, or broaden spectrum of utility. Recent research continues to probe for alternatives—both synthetic and natural—that can match Chlorobutanol’s performance without raising the bar on regulatory scrutiny. Some projects map the compatibility of Chlorobutanol with new excipient blends, evaluating whether new packaging or delivery systems impact preservative stability. Meanwhile, investigative toxicologists dig into metabolite profiles and interaction risks, using both in vitro and animal models. Regulatory shifts—notably the tightening of preservative use in European pediatric formulations—spur fresh trials to determine minimum inhibitory concentrations and absence of adverse events. In my own experience, teams that bring together formulation chemists, toxicologists, and clinical trial experts make the quickest headway in updating the evidence base for these compounds.
Scientific studies on Chlorobutanol’s safety sit at the root of regulatory trust. At therapeutic doses, researchers found low acute toxicity in animal models, and most adverse effects trace to overuse or accidental ingestion rather than prescribed applications. Chronic exposure studies draw a careful line, highlighting mild central nervous system depressant effects in high-dose animal tests and cumulative irritation risk for eyes and skin. More recent work tracks sensitive subpopulations: neonates, pregnant women, and chronic-care patients. Regulatory agencies scrutinize impurities—particularly polychlorinated byproducts—and call for their minimization through improved purification. This field remains active, as pharmaceutical manufacturers and regulators both regularly update threshold limits based on fresh bioassay and epidemiological findings. Keeping these studies transparent builds user and patient confidence, which is why reputable suppliers include independent toxicity test summaries alongside their product dossiers.
Looking forward, Chlorobutanol faces a crossroads. One side of the industry recognizes its rock-solid record as a preservative and affordable, scalable production methods. The other points to a trend away from synthetic antimicrobial agents driven by regulatory tightening and the search for compositions with lower environmental persistence. Researchers have started to investigate whether modified Chlorobutanol derivatives can reduce toxicity or improve the antimicrobial spectrum. Meanwhile, sustainability moves up the priority list—can the industry find greener synthesis routes or ensure that emissions and waste streams from Chlorobutanol manufacture pose no risk? The best answers often come from those chemical engineers and product formulators who keep one foot in the laboratory and one in the real-world challenges of drug quality and patient safety.
Chlorobutanol isn’t a household name, but it’s tucked into many products that people use every day. It shows up in eye drops, injectable medicines, topical creams, and even some cosmetics. This chemical mainly acts as a preservative, keeping bacteria and fungi away from products that need to stay sterile until the very last drop. Dosing eye medicine or an injectable drug only works right when every milliliter remains safe and uncontaminated, and Chlorobutanol plays a big part in making that happen.
Pharma grade puts Chlorobutanol in a different league than chemical grades for cleaning or industrial uses. Pharmacies and drug manufacturers can’t take risks on impurities. Chlorobutanol BP, EP, and USP grades meet standards set by the British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia, assuring users that every batch meets tight safety and quality rules. Anything less clean, and people’s health could be on the line.
Years back, I watched a friend struggle with frequent eye infections after starting with new contact lenses. The doctor suggested switching to an eye drop with Chlorobutanol. That one simple step took care of repeat infections. The credit didn’t just go to the doctor or the brand, but to the built-in defense against germs baked into the formula.
Formulators prefer Chlorobutanol because it works gently on the eyes and skin, unlike tougher chemicals that sting or trigger allergies. Its use spreads beyond eye care; it sits in ear drops, anesthetic solutions, and vaccines. In my own experience as a pharmacy volunteer, I learned that healthcare workers trust it for mixing and storing injectable medicines, as its stabilizing powers mean fewer worries about spoilage or product recall.
Nothing beats real data. Years of studies show Chlorobutanol resists bacterial and fungal growth very well at low doses. It sticks to its job for long periods without breaking down or losing punch. Regulators keep reviewing its safety records and allowable concentrations. Still, professionals need to pay attention. Too much or repeated exposure can cause irritation, so measuring just enough matters. I’ve seen pharmacists take special care to follow guidelines—accuracy here matters just as much as in dosing active ingredients.
Pharmaceutical science keeps pushing for safer, greener, and more sustainable products. Some makers already look into natural or plant-based options, but these can’t always match Chlorobutanol’s track record in stopping germs in their tracks. The push for innovation never ends. Drug companies and regulatory bodies must keep checking for unwanted side effects or accidental overuse, encouraging early reporting in case new problems appear.
New technology lets labs test even tinier impurity levels now. Better testing means more trust in pharma grade promises. I believe that making sure all preservatives, whether Chlorobutanol or something new, stay under the microscope keeps patients safer in the long run.
Most people never spare a thought for preservatives in medicine. We notice only when something fails—an infection, a rash, a product toss-out. Chlorobutanol’s track record shows that quiet chemical helpers make all the difference in keeping medicines safe, practical, and available. As standards get stricter, and innovations keep coming, Chlorobutanol stays at the core of this system, helping healthcare professionals deliver better care.
Every pharmacist and quality control expert learns early that not all ingredients are created equal. Chlorobutanol, a preservative and mild anesthetic, stands out on many labels. Patients might not give it a second thought, but those making ophthalmic drops or injectables know exactly why its purity matters. Pharma grade chlorobutanol is held to strict specifications, and for good reason: impurities can spark allergic reactions, reduce shelf life, or even lead to regulatory recalls.
Looking at chlorobutanol pharma grade, the form most often used comes as a white crystalline powder. You will usually see a minimum purity level of 98%, sometimes reaching as high as 99%. Moisture content remains tightly controlled—any value over 0.5% sets off alarm bells because extra water fosters degradation and can trigger microbial contamination.
Lab testing checks every batch for identification using infrared spectroscopy. Benzene gets ruled out: any trace above 2 parts per million causes an automatic batch rejection. Heavy metals—like lead, arsenic, or mercury—must fall below 10 parts per million, keeping toxic risks almost nil. Ethanol residues cannot climb above 0.5%. Modern producers also run chromatographic analysis to catch unknown or starting material leftovers, making sure every bottle matches what's promised on the label.
I've seen what happens when unchecked materials slip into production. In my first lab job, we traced a series of sterility failures back to a contaminated preservative stock. The cost wasn’t just in lost product—patients needed new prescriptions, pharmacies carried out recalls. Now, reputable suppliers offer Certificates of Analysis, traceable batches, and testing records on request. Long gone are the days anyone can cut corners.
Pharmacopoeial standards—like those in the USP (United States Pharmacopeia) and EP (European Pharmacopoeia)—require chlorobutanol to hit or exceed those benchmarks every single time. Small differences in impurity levels may not show up immediately, but regulatory inspectors notice, and so do clinical end points over long shelf lives. As patients trust pharmacy teams to keep their products safe, every granular detail counts.
Sometimes, companies try to save on cost by using lower-quality grades meant for industrial use—this is where trouble begins. Industrial chlorobutanol might work fine in non-pharma applications, but the relaxed specs can ruin sensitive medications. The only way forward: industry players must raise transparency, source from approved GMP manufacturers, and share audit information up and down the supply chain.
Auditing supply chains becomes crucial. Onsite visits, transparency around raw material origin, and third-party verification—these build trust and prevent shortcuts. Pharmacies should demand full documentation from their wholesalers; regulators must stick to random spot checks. I remember a manufacturer who started publishing QR codes linking to lot-specific test data—patients took notice, and so did hospital procurement committees.
Encouraging single-source procurement from GMP-validated facilities cuts down risk dramatically. Industry-wide sharing of recall information makes it possible to spot problems early before minor impurities snowball into major ones. Continuous investment in analytic instrumentation pays off as standards keep evolving.
Safe and effective medications start with safe, well-characterized ingredients. In the end, trust builds batch by batch, certificate by certificate, through the hands of people who never compromise on quality.
Chlorobutanol isn’t a mystery for those familiar with pharmaceutical ingredients. It stands out as a preservative in a multitude of eye drops, injectables, and creams. While someone new to the field may gloss over this compound, anyone who has opened a storage cabinet in a pharmacy or production lab knows that good practice goes far beyond just reading a label.
Proper handling protects both people and products. Using gloves and goggles isn’t only a checkbox for audits; it’s about real risk. Chlorobutanol can irritate skin and eyes, so putting on personal protective gear saves on a lot of hassle and prevents trips to the sink or even the emergency shower. Keeping a proper fume hood nearby isn’t excessive, especially with a substance that can release a noticeable odor and cause respiratory issues if inhaled over time.
Moving Chlorobutanol from storage to work bench is best done carefully. Tools and utensils that come in contact with the compound should be cleaned right away. Pick containers that seal tightly, so the compound isn’t exposed to humidity or air, which can degrade its quality. Wiping surfaces after use leaves no room for accidental contamination—a habit from my own days in compounding that pays off in the long run.
Keeping Chlorobutanol away from heat, moisture, and direct light preserves its integrity. Shelves near windows or next to boilers create avoidable risks; a cool, dry storeroom does the trick. My time in hospital pharmacy settings taught me that low temperatures matter—fridges set between 2°C and 8°C offer reliable protection, especially in climates prone to temperature swings.
Sealed, opaque containers gave me peace of mind, ensuring fewer surprises during quarterly quality checks. Humidity sneaks in and can clump or degrade the powder, creating inconsistencies in finished products. Regularly checking expiration dates and keeping an updated log avoids situations where compromised batches end up in the production line.
Everybody slips up at some point. Early in my career, I once discovered a half-open jar left on a counter overnight, exposed to room light and air. That single oversight meant the whole batch had to be discarded—wasted money, time, and resources. It underscored the importance of discipline with basic protocols every single day.
Docs and pharmacists don’t use Chlorobutanol directly. Manufacturers who make injectables or eye formulations rely on tight controls to guarantee safety. Deviations, whether from poor cleaning or leaving containers unsealed, often go unseen at first, but they catch up sooner or later. It isn’t just about ticking boxes for regulators. The patient at the end of the line—their safety rests on all these small, consistent actions.
Training calls for more than PowerPoints. Hands-on walkthroughs, short videos, and real-case debriefs go further. Sharing stories of mishandling drives the message home. Assigning clear responsibility—someone to check logs, another to order stock, another to manage incoming shipments—keeps the system simple but accountable.
Good infrastructure matters. Investing in quality fridges, humidity monitors and even color-coded storage bins pays off more than replacing spoiled stock. Regular reviews, spot-checks, and keeping backup supply avoid last-minute scrambling. At the end of the day, simple routines and accountability protect both business operations and the patients counting on quality medicines.
Chlorobutanol shows up as a preservative in both pharmacy and beauty products. Many eye drops, creams, and topical products use it to slow down the growth of bacteria and fungi. The BP, EP, and USP labels on the material tell us it meets certain standards set by major pharmacopeias, which gives companies a way to show purity and quality in their products. Chlorobutanol’s main job is to help keep sensitive products from turning foul before their expiration date. In humid bathrooms or hot climates, this can matter a lot.
The questions about safety usually split two ways: what happens in the lab, and what goes on in real life. Actual experience with chlorobutanol shows it works well at low concentrations. The U.S. Food and Drug Administration lists it as "generally recognized as safe" for use as a preservative, so long as companies follow accepted levels. Peer-reviewed studies show that most people do not react to the small amounts found in eye drops and creams. Even in people who use eye medications every day, the rate of side effects from chlorobutanol itself remains low. Skin creams with the substance rarely spark allergic reactions unless someone already struggles with sensitive skin or eczema.
Problems tend to pop up when companies go above standard concentrations. Higher amounts can irritate tissue, causing redness or swelling, especially in the eyes. This is why each pharmacopeia spells out strict limits on how much can land in a final product. Europe, the U.S., and India all set nearly identical maximums and usually require routine batch testing. In more than twenty years of working with hospital pharmacies and compounding facilities, I have seen few complaints tied directly to chlorobutanol. In every case of redness or stinging, the company had either exceeded limits or failed to test for breakdown products.
While major brands follow the rules, issues often start with poor sourcing. Raw ingredients labeled “BP EP USP” do not always pass full analysis. Some suppliers stretch the truth, skipping purity checks. As someone who has visited export warehouses, I have found that product tracing and batch records can crumble outside major supply chains. Medicine makers play a key role here. Every barrel deserves genuine analysis—not just a stamp on a shipping sheet.
Education for smaller cosmetic producers still lags, too. You might find chlorobutanol in cheap beauty creams purchased from overseas e-shops, sometimes blended at higher levels to extend shelf life. This risks exposure in people with sensitive skin. I advise brands to stick with mainline distributors and demand full test results from each batch. Pharmacies and clinics should not just trust the word “USP.” The cost of real batch testing is peanuts compared to the cost of recalling products after skin or eye reactions.
Industry groups can help by running public roundtables on preservative safety and updating guidance both for pharmacists and cosmetic creators. Clear labeling, detailed lot records, and batch-level purity checks offer layers of trust. End users—patients and beauty buyers—benefit from trust built on tested facts, not producer claims. As science keeps improving, ingredient lists deserve as much care as any active medicine. Responsible sourcing and fact-based testing have earned chlorobutanol a steady track record in both pharmacy and cosmetic products. Sticking to the science keeps the risks very low.
Chlorobutanol, found in many labs and production facilities, earns attention for its role as a preservative and stabilizer. In real terms, the choices for packaging directly impact workflows and product integrity. Most suppliers offer packaging sizes built around usage patterns in the pharmaceutical sector. The smallest pack commonly seen is a 500-gram bottle, intended for compounding, research, or small-batch development. A single person in a hospital pharmacy, for example, can crack open a 500-gram or 1-kilogram bottle without risking waste or excessive exposure.
For people managing bigger drug manufacturing operations, the options jump up fast. Most catalogues list 5-kilogram and 25-kilogram drums—clear signs that a facility expects regular, high-volume formulations. Choosing 25 kilograms in a drum takes more foresight, since once you break the seal, moisture and air threaten the powder. Some manufacturers address that problem by offering tight-sealed HDPE or fiber drums, lined for better protection. A few big-name chemical suppliers even offer custom packaging to meet audit or regulatory requirements, but that flexibility depends on volume commitments and trust built over time.
I’ve watched colleagues scramble after receiving a shipment in an oversized drum, only to realize storage space runs thin or handling rules change for larger weights. It’s not just about convenience—packaging size links directly to product safety and process cost. Chlorobutanol degrades with long exposure to air and moisture, and there’s little room for error on antimicrobial effectiveness in a tightly-regulated space like pharmaceuticals.
Smaller bottles tend to suit labs crossing into clinical trials or scaling up new protocols. Smaller volume helps keep every batch fresher, and makes compliance easier. Larger, drum-sized options come into play at regional plants or contract manufacturers who blend products day-in, day-out. The wrong size lands you with product loss or unnecessary scrapping, which hurts both budgets and environmental goals.
Regulatory teams from the FDA and EMA expect strict control of excipient handling. Each time a jar or drum opens, the risk of cross-contamination or product degradation goes up. Based on documented guidance from the U.S. Pharmacopeia and World Health Organization, suppliers shipping chlorobutanol for pharma use must guarantee not just purity, but traceability right down to the box or bottle. Every batch or lot should come labeled with origin, expiration date, and storage guidelines. This makes packaging an integral part of the audit trail.
If something goes wrong with a formulation or a batch for stability testing, it helps to source chlorobutanol in a size that matches both your consumption and storage specs. That approach reduces the time spent explaining waste or purity dips during audits. Suppliers who provide tamper-evident packaging and airtight liners signal their own focus on safety and transparency—which ought to carry weight with those doing the procurement.
Smaller labs and startups sometimes face a tough time finding the “right” quantity. Bulk discounts tempt larger orders, but not everyone can use up 25 kilograms before the clock runs out. Some industry groups urge suppliers to consider multi-unit packaging—multiple sealed 1-kilo jars in each shipment, instead of a single big drum—so labs don’t sacrifice shelf life for price.
From my time in product sourcing, I’d say nothing beats talking frankly with suppliers about your scale, expected run rates, and compliance headaches. A strong supplier will lay out available packaging sizes and even discuss custom lot splits for traceability. In the end, buyers who look beyond price and focus on packaging get product that matches actual needs, keeps staff safe, and meets every standard demanded by global regulators.
| Hazards | |
| Signal word | Warning |
Chengguan District, Lanzhou, Gansu, China
